Oramed Pharmaceuticals Inc
ORMP2.110USD
-0.010-0.47%
交易中 （美東）報價延遲15分鐘
86.19M總市值
虧損本益比TTM
關於 Oramed Pharmaceuticals Inc 公司
Oramed Pharmaceuticals Inc. 是一家擁有技術平臺、從事藥物解決方案研發的製藥公司。該公司開發了一種口服劑型，旨在耐受胃的惡劣環境並有效遞送活性生物胰島素或其他蛋白質。其蛋白質口服遞送 (POD) 技術旨在保護藥物完整性並增加吸收。其產品線包括 ORMD-0801（口服胰島素）糖尿病、ORMD-0801（口服胰島素）NASH 和 ORMD 0901（口服 GLP-1）。其口服胰島素 (ORMD-0801) 有可能通過在治療早期階段口服胰島素來創造糖尿病治療的新範例。其口服胰島素膠囊 (ORMD-0801) 在早期臨牀試驗中顯示出降低肝臟脂肪含量的效果。該公司還在開發一種口服胰高血糖素樣肽-1 (GLP-1) 類似物膠囊 (ORMD-0901)，這是一種刺激胰腺分泌胰島素的腸促胰島素激素。
公司簡介
公司代碼ORMP
公司名稱Oramed Pharmaceuticals Inc
上市日期Apr 01, 2002
CEOMr. Nadav Kidron
員工數量13
證券類型Ordinary Share
年結日Apr 01
公司地址1185 Avenue Of The Americas, 3Rd Floor
城市NEW YORK
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編10036
電話16468441164
網址https://oramed.com/
公司代碼ORMP
上市日期Apr 01, 2002
CEOMr. Nadav Kidron
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Nadav Kidron
Mr. Nadav Kidron
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.06M
+2.09%
Mr. Benjamin Shapiro
Mr. Benjamin Shapiro
Independent Director
Independent Director
1.93M
-1.56%
Dr. Miriam Kidron, Ph.D.
Dr. Miriam Kidron, Ph.D.
Chief Scientific Officer, Director
Chief Scientific Officer, Director
777.83K
-0.45%
Mr. Avraham Gabay, CPA
Mr. Avraham Gabay, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
153.01K
+11.41%
Mr. Leonard Sank
Mr. Leonard Sank
Independent Director
Independent Director
30.01K
-70.44%
Mr. Yehuda Reznick
Mr. Yehuda Reznick
Independent Director
Independent Director
19.74K
-63.39%
Dr. Daniel Aghion
Dr. Daniel Aghion
Independent Director
Independent Director
18.82K
-67.09%
Mr. Joshua Hexter
Mr. Joshua Hexter
Chief Operating and Business Officer
Chief Operating and Business Officer
--
--
Dr. Arie Mayer, Ph.D.
Dr. Arie Mayer, Ph.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Nadav Kidron
Mr. Nadav Kidron
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.06M
+2.09%
Mr. Benjamin Shapiro
Mr. Benjamin Shapiro
Independent Director
Independent Director
1.93M
-1.56%
Dr. Miriam Kidron, Ph.D.
Dr. Miriam Kidron, Ph.D.
Chief Scientific Officer, Director
Chief Scientific Officer, Director
777.83K
-0.45%
Mr. Avraham Gabay, CPA
Mr. Avraham Gabay, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
153.01K
+11.41%
Mr. Leonard Sank
Mr. Leonard Sank
Independent Director
Independent Director
30.01K
-70.44%
Mr. Yehuda Reznick
Mr. Yehuda Reznick
Independent Director
Independent Director
19.74K
-63.39%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月18日 週五
更新時間: 7月18日 週五
持股股東
股東類型
持股股東
持股股東
佔比
BML Capital Management LLC
7.40%
Kidron (Nadav)
5.05%
Shapiro (Benjamin)
4.74%
Murchinson Ltd.
4.29%
Boothbay Fund Management, LLC
2.07%
Other
76.46%
持股股東
持股股東
佔比
BML Capital Management LLC
7.40%
Kidron (Nadav)
5.05%
Shapiro (Benjamin)
4.74%
Murchinson Ltd.
4.29%
Boothbay Fund Management, LLC
2.07%
Other
76.46%
股東類型
持股股東
佔比
Individual Investor
15.20%
Investment Advisor
9.04%
Investment Advisor/Hedge Fund
8.13%
Hedge Fund
1.17%
Research Firm
0.72%
Bank and Trust
0.06%
Other
65.68%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
124
14.01M
34.29%
-878.39K
2025Q1
140
14.12M
34.57%
-1.05M
2024Q4
166
12.68M
31.46%
-741.80K
2024Q3
167
11.86M
29.21%
-291.74K
2024Q2
182
11.21M
27.68%
-1.03M
2024Q1
228
10.28M
25.41%
-3.86M
2023Q4
234
9.69M
24.13%
+273.21K
2023Q3
243
6.84M
17.06%
-2.85M
2023Q2
244
6.81M
17.03%
-4.46M
2023Q1
244
6.64M
16.80%
-2.29M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BML Capital Management LLC
3.02M
7.39%
+376.84K
+14.25%
Mar 31, 2025
Kidron (Nadav)
2.02M
4.95%
-96.03K
-4.54%
Mar 27, 2025
Shapiro (Benjamin)
1.96M
4.81%
+34.65K
+1.80%
Jun 05, 2025
Murchinson Ltd.
1.75M
4.29%
+800.00
+0.05%
Mar 31, 2025
Boothbay Fund Management, LLC
845.49K
2.07%
+300.00
+0.04%
Mar 31, 2025
Hexter Joshua
812.17K
1.99%
+126.83K
+18.51%
Feb 11, 2025
Kidron (Miriam)
781.33K
1.91%
-6.88K
-0.87%
Mar 27, 2025
Two Sigma Investments, LP
277.42K
0.68%
-74.36K
-21.14%
Mar 31, 2025
Rathbones Investment Management Limited
236.80K
0.58%
-53.00K
-18.29%
Mar 31, 2025
Li (Xiaopeng)
218.60K
0.54%
--
--
Mar 27, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
Amplify BlueStar Israel Technology ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
SPDR Portfolio Developed World ex-US ETF
0%
Avantis US Small Cap Equity ETF
0%
SPDR S&P International Small Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Equity ETF
0%
iShares Micro-Cap ETF
佔比0.02%
Amplify BlueStar Israel Technology ETF
佔比0%
Invesco NASDAQ Future Gen 200 ETF
佔比0%
SPDR Portfolio Developed World ex-US ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
SPDR S&P International Small Cap ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
Avantis US Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
